Recent Updates
Recently added Catalysts
RCEL Negative Sentiment Score: 30/100

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Key Takeaway: AVITA Medical, Inc. is under investigation by the Portnoy Law Firm for potential securities fraud affecting its investors. The inquiry follows the company's recent financial disclosure, which highlighted a backlog of unpaid claims for its Recell product, resulting in decreased utilization and significant revenue implications. Following this news, AVITA's share price dropped over 21%, raising concerns among investors. The law firm is inviting affected investors to seek legal recourse for their losses.

Market Sentiment Analysis

CONCERNS & RISKS

  • AVITA Medical is under investigation for possible securities fraud.
  • The company's financial results revealed a significant backlog in unpaid provider claims, negatively impacting revenue.
  • The share price plummeted by approximately 21% following the announcement of the investigation and financial issues.
  • Uncertainty over payment expectations has led to reduced demand for AVITA's Recell product.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc. (“Avita” or “the Company”) (NASDAQ : RCEL) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Avita investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On August 7, 2025, AVITA released its second quarter 2025 financial results, disclosing that “a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand.” The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to establish pricing for its wound care product, Recell, either failed to assign an appropriate price or failed to adjudicate claims in a timely manner. As a result, claims from January through June accumulated, creating a significant backlog of unpaid and underpaid claims to providers. This uncertainty over payment expectations and timelines, according to the Company, led to reduced utilization of Recell during the first half of the year.
On this news, AVITA’s share price fell $1.13, or approximately 21%, from $5.38 on August 7, 2025, to $4.25 on August 8, 2025.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
Attorney Advertising

Tags

Frequently Asked Questions

What investigation is the Portnoy Law Firm conducting?

The Portnoy Law Firm is investigating potential securities fraud involving AVITA Medical, Inc.

How can AVITA investors seek legal advice?

Investors can contact attorney Lesley F. Portnoy at 310-692-8883 or via email.

What caused AVITA's share price to drop?

A backlog in unpaid claims for Recell procedures led to a significant share price decline.

Is there a cost to consult with the Portnoy Law Firm?

No, investors can contact the firm at no cost for a case evaluation.

What result did AVITA's financial disclosure have on its stock?

AVITA's stock fell about 21% after revealing a backlog of unpaid claims.

Last updated: Aug 28, 2025